Piperacillin, ticarcillin, and carbenicillin were administered intravenously to 10 healthy volunteers in a three-way, crossover study. The pharmacokinetics of the three drugs were in general quite similar. The peak serum concentration of piperacillin achieved at the end of a 30-min intravenous infusion was 63.5 ± 27.6 ,ug/ml. During the first 8 h, 67.5% of the dose of piperacillin was excreted in the urine, and the urinary concentration was extremely high. All three penicillins had high volumes of distribution. The serum half-life of the beta elimination phase of carbenicillin was lower than that of either piperacillin or ticarcillin. The volunteers experienced no adverse reactions from the administration of the drugs.
Piperacillin, ticarcillin, and carbenicillin were administered intravenously to 10 healthy volunteers in a three-way, crossover study. The pharmacokinetics of the three drugs were in general quite similar. The peak serum concentration of piperacillin achieved at the end of a 30-min intravenous infusion was 63.5 ± 27. 6 ,ug/ml. During the first 8 h, 67 .5% of the dose of piperacillin was excreted in the urine, and the urinary concentration was extremely high. All three penicillins had high volumes of distribution. The serum half-life of the beta elimination phase of carbenicillin was lower than that of either piperacillin or ticarcillin. The volunteers experienced no adverse reactions from the administration of the drugs.
Carbenicillin, a carboxypenicillin derivative, was the first beta-lactam antimicrobial agent with antibacterial activity against Pseudomonas aeruginosa introduced into clinical use (1, 9, 11). Ticarcillin, an alpha carboxythienyl derivative of 6-aminopenicillanic acid, is two to four times as active against strains of P. aeruginosa as carbenicillin in vitro (13) . Piperacillin (sodium is a new semisynthetic penicillin. In vitro studies have shown that piperacillin has greater activity than either carbenicillin or ticarcillin against a variety of gram-positive and gram-negative organisms, including P. aeruginosa, Proteus sp., and Klebsiella sp. (4, 5, 10, 12, (15) (16) (17) .
We report the comparative pharmacokinetic properties of piperacillin, ticarcillin, and carbenicillin derived from a three-way crossover study of these compounds in normal human volunteers. All volunteers fasted and were voided before the administration of the compounds. Food and fluid intake resumed 2 h after injection. Volunteers remained sedentary during the study period. The following laboratory studies were made before and after administration of the compound: hemogram, urinalysis, blood urea nitrogen, serum creatinine, serum glutamic oxalacetic transaminase, serum glutamic pyruvic transaminase, alkaline phosphatase, bilirubin, phosphorous, sodium, potassium chloride, calcium, albumin, globulin, cholesterol, triglycerides, and total serum lipids.
MATERIALS AND METHODS
The data were analyzed with a program written for a Wang 700 B programmable calculator to derive the pharmacokinetic parameters. The data were fitted to two regression lines, and the following pharmacokinetic parameters based on a two-compartment model (6) 
RESULTS
In general, the pharmacokinetic properties of piperacillin, ticarcillin, and carbenicillin were quite similar. The mean serum concentrations of the three compounds after infusion of 2-g doses over a period of 30 min are given in Table 1 . The mean peak serum concentrations achieved at the end of the infusions were 63.5, 60.9, and 53 ,ug/ml for piperacillin, ticarcillin, and carbenicillin, respectively. The serum concentrations observed for the three compounds were not statistically different. At 3 h after the infusion of 2-g doses of piperacillin, an average concentration of 4.3 ug/ml was still present in serum. By 4 h, the mean concentration had fallen to 1.8 ,tg/ml.
Only very small amounts of piperacillin were detectable at 8 h after the completion of the infusion.
The pharmacokinetic parameters derived for the three drugs from the mean serum concentrations are given in Table 2 . The elimination constants (Ke) and the compartmental transfer constants (K21 and K12) were similar for the three drugs. The areas under the curve (A) found for piperacillin and ticarcillin were almost identical and were larger than that derived for carbenicillin. This was paralleled by the greater half-lives of the beta phase (t,12fl) for piperacillin and ticarcillin than for carbenicillin. Piperacillin had the largest total apparent volume of distribution of the three drugs. However, the volumes of distribution in the steady state were similar for all three drugs. These volumes were quite large and indicate that the drugs are widely distributed in the body. As expected, the plasma clearances of all three drugs were similar.
The urinary concentrations of the three compounds were quite high (Table 3 ). The mean concentration of piperacillin in urine during the (Table 3) . However, the amount excreted during the first 8 h for ticarcillin (40%) was lower than that excreted for either piperacillin (67.5%) or carbenicillin (79.2%).
Volunteers did not complain of pain at the site of infusion, and no adverse reactions to the drugs occurred. Laboratory tests performed before and after administration of the drugs remained normal, DISCUSSION The data presented here from the three-way crossover study of the three penicillins, piperacillin, ticarcillin, and carbenicillin, show that the pharmacokinetic behavior of the three drugs is nearly identical. Our results for ticarcillin and carbenicillin generally agree with those previously reported by other workers (7, 13, 14) . Our data for piperacillin are in accord with those recently presented by Evans and co-workers (3). However, we caution that our study cannot be directly compared with previous studies of carbenicillin and ticarcillin, or the recent pharmacological study of piperacillin, because the dosages, methods of infusion, methods of calculation, and patient selection within them are different.
We found a shorter half-life for carbenicillin, compared with ticarcillin, as had been previously reported (13) . The half-lives of the beta phase of piperacillin and ticarcillin were almost the same. The renal elimination of ticarcillin was lower than that found for carbenicillin and has also been previously noted (13) . Cole et al. (2) attributed this to the increased conversion of ticarcillin to penicilloic acid.
Interestingly, Evans and co-workers (3) found that both the volume of distribution and the urinary excretion of piperacillin varied with the dose. At lower doses of piperacillin urinary excretion was lower but the volume of distribution was higher. It was suggested that the higher values for the volume of distribution at lower dosages may indicate a tendency to saturate particular tissues, so that increasing the dose is not paralleled by an increase in tissue concentration. The area under the curve increased with larger doses of piperacillin but did not change with the duration of the infusion.
Since the pharnacokinetic properties of piperacillin, ticarcillin, and carbenicillin are so similar, the antibacterial properties of the three drugs must be examined in an attempt to detect possible advantages of piperacillin over the two older penicillins. Clearly, piperacillin has a greater specific activity against most gram-neg-ANTIMICROB. AGENTS CHEMOTHER.
ative strains when compared with carbenicillin and ticarcillin (4, 10, 12, (15) (16) (17) . Piperacillin is as active as ampicillin against Streptococcus faecalis and inhibits 70% of the strains of Bacteroides fragilis at a concentration of 12.5 ug/ml (4). More importantly, piperacillin is by far the most active penicillin against P. aeruginosa. At least 90% of the strains of P. aeruginosa are inhibited at a concentration of 12.5 ,Ag of piperacillin per ml (4, 17) . Fifty percent of the strains of P. aeruginosa were inhibited at a concentration of 2 ,ug/ml, and 83% were inhibited at a concentration of 4 
